This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.
Exenatide is a synthetic GLP-1 receptor agonist originally derived from Gila monster venom (exendin-4). It promotes satiety, regulates blood sugar, and emerging research suggests neuroprotective effects including enhanced neurogenesis and reduced neuroinflammation.
Common Dose
0.01mg
Dose Range
0.005โ0.02mg
Frequency
twice daily (injectable)
Half-Life
2.4 hours
Onset
30 min
Duration
6 hours
Cycling
Not required
Legal Status
legal
Exenatide binds and activates GLP-1 receptors in the pancreas, gut, and brain. In the CNS, it enhances insulin signaling, promotes BDNF expression, reduces neuroinflammation via NF-ฮบB inhibition, and supports mitochondrial function in neurons.
Neurotransmitter Pathways
โ ๏ธ Start low and increase gradually. Individual responses vary.
Potential Side Effects
Contraindications
Drug Interactions
No cycling required โ can be taken daily.
Get the complete research brief for Exenatide
PubMed citations, dosing protocols, interaction data, and stacking recommendations โ delivered to your inbox.